Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms

Chovanec, J.; Tunc, I.; Hughes, J.; Halstead, J.; Mateja, A.; Liu, Y.; O’Connell,; Kim, J.; Park, Y. H.; Wang, Q.; Le, Q.; Pirooznia, M.; Trivedi, N. N.; Bai, Y.; Yin, Y.; Hsu, A. P.; McElwee, J.; Lassiter, S.; Nelson, C.; Bandoh, J.; DiMaggio, T.; Šelb, J.; Rijavec, M.; Carter, M. C.; Komarow, H. D.; Sabato,; Steinberg, J.; Hafer, K. M.; Feuille, E.; Hourigan, C. S.; Lack, J.; Khoury, P.; Maric, I.; Zanotti, R.; Bonadonna, P.; Schwartz, L. B.; Milner,; Glover, S. C.; Ebo, D. G.; Korošec, P.; Caughey, G. H.; Brittain, E. H.; Busby, B.; Metcalfe,; Lyons, J. J.

Links

ORCID

Tools

Export citation

Search in Google Scholar

Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms

Published in 2022 by J. Chovanec, I. Tunc, J. Hughes, J. Halstead, A. Mateja, Y. Liu, O’Connell, J. Kim, Y. H. Park, Q. Wang, Q. Le, M. Pirooznia, N. N. Trivedi, Y. Bai, Y. Yin and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload